Research
Evidence, read off the primary source — page 2
No pattern-matched citations and no PMIDs pulled from memory. Every regulatory date, study, and label quote below was checked against its primary source before publication — see each article's reference list. 134 articles published so far.
How we verify a source
A PubMed citation is checked against PubMed's own record, not typed from recall. A regulatory page is read at the source and quoted, not paraphrased from a secondary blog. If a claim cannot be verified this way, it is softened or removed — never guessed.
Filter by topic
Showing 25–48 of 134 articles
Evidence review
NMN vs NAD+: What the Evidence Actually Shows
NMN and NAD+ are sold as the same idea and tested in opposite ways: NMN orally, NAD+ by injection. Here is what each trial record actually contains.
ReadEvidence review
Ozempic Hands: What Is Actually Happening, and What the Evidence Shows
"Ozempic hands" is the same fat-loss mechanism as Ozempic face, applied to the backs of your hands — but with no GLP-1-specific study yet. Here's what's real.
ReadEvidence review
Sermorelin Tablets vs. Injections vs. Nasal Spray: Does Oral Sermorelin Work?
Human studies of sermorelin-type peptides used injections, IV or nasal spray. None tested a tablet. What the nasal data show, and what each form costs.
ReadEvidence review
SS-31 (Elamipretide): What the Evidence Actually Shows
SS-31/elamipretide just got real FDA accelerated approval for Barth syndrome — on small, non-randomized data. A larger trial for a different use failed.
ReadEvidence review
Tesamorelin Before and After: What the Trials Measured (Belly Fat, Not Muscle)
In its FDA trials, tesamorelin cut deep belly fat 14–18% in 26 weeks with no weight change — and the fat came back when people stopped. What that means for you.
ReadEvidence review
Tesamorelin Dosing: What the Egrifta FDA Label Actually Specifies
Tesamorelin's dose is on a real FDA label — 1.4 mg (Egrifta SV) or 1.28 mg (Egrifta WR), daily, for a specific HIV indication. Here's exactly what it says.
ReadEvidence review
Tesamorelin Side Effects: What Egrifta's Own FDA Label Reports
Tesamorelin has a current FDA label, unlike sermorelin. Here's what it warns about — neoplasms, IGF-1, glucose intolerance, and a real statistical tension.
ReadEvidence review
Does Tirzepatide Cause Hair Loss? What the 2026 Evidence Actually Shows
A real signal exists, and no prospective trial has tested it. The likely mechanism is how fast you lost weight, not the drug itself. Here's the evidence.
ReadEvidence review
GLP-1 Patches: Do They Work, and What Is Actually in Them?
Semaglutide and tirzepatide are 8 to 10 times too large to cross intact skin passively, and no transdermal version exists. So what is in the patch?
ReadEvidence review
How Long Tirzepatide Takes to Work: What the Trials Actually Measured
The famous ~21% figure is a 72-week result, and the label says at least 52 of those weeks were at the maintenance dose. Here's the real clock.
ReadEvidence review
Is Zepbound the Same as Tirzepatide? Brand, Molecule, and What Actually Differs
Zepbound and Mounjaro are the same molecule with different approved uses — and one covers children while the other doesn't. Here's what the labels say.
ReadEvidence review
Oral Tirzepatide: Does It Exist, and Does It Work?
Every tirzepatide product on the federal label database is an injection — all eight of them. So what exactly are oral tirzepatide sellers selling?
ReadEvidence review
Units vs. Milligrams on a GLP-1 Syringe: Why "40 Units" Is Not a Dose
A syringe unit is a volume, not a dose. The same 40 units can be four different milligram amounts. Here's the arithmetic and the number you must find first.
ReadEvidence review
Where to Inject Tirzepatide and Semaglutide: What the Labels Actually Say
Tirzepatide and semaglutide labels do not give the same injection sites. One puts the upper arm behind a caregiver; the other doesn't. Here's each, quoted.
ReadEvidence review
NAD+ Nasal Spray: What the Evidence Actually Shows
Six telehealth providers sell NAD+ nasal spray. The only published study of that route used cultured cells and mice — and tested smell, not energy.
ReadEvidence review
BPC-157 Oral vs. Injection: Can a Capsule Do What a Shot Does?
Oral BPC-157 capsules cost less than vials. Here's what the published research actually administered, by route — and the one number nobody has measured.
ReadEvidence review
CJC-1295 Dosage: What the Only Human Trial Used
CJC-1295 has a real subcutaneous human dose-ranging trial — but only the DAC form. The version usually sold has no published human dose, or even a route.
ReadEvidence review
GHK-Cu Dosage: What the Studies Actually Administered
No human study has ever dosed injectable GHK-Cu. Here's every dose the cell-culture, animal, and topical human studies actually used — and what it isn't.
ReadEvidence review
GLP-1 and Thyroid Cancer Risk: The Warning and the Human Data
Semaglutide carries a boxed warning about thyroid C-cell tumors. What the labels actually say, and what the human cohort studies have and have not found.
ReadEvidence review
GLP-1 Drugs and Alcohol: What the Trials Actually Show
Three randomized trials of semaglutide for alcohol use disorder have reported. Two hit their primary endpoint, one missed. What each actually found.
ReadEvidence review
Glutathione Dosage and Side Effects: What Trials Used
Real randomized glutathione doses exist — for oral, nasal, and inhaled routes. For the IV form most sellers ship, the best synthesis says don't give it.
ReadEvidence review
Ipamorelin Dosage: What the Studies Actually Administered
There is no established ipamorelin dose. Every human study used IV infusion — nobody has published a subcutaneous dose, the route the market injects.
ReadEvidence review
NAD+ Dosage and Side Effects: What Studies Actually Used
No established NAD+ dose exists. Here's what the one IV infusion study and the oral precursor trials actually administered — and where the record stops.
ReadEvidence review
Peptide Reconstitution and Storage: What FDA Labels Say
Which diluent, what volume, what temperature, how long it keeps — read off seven current FDA labels, which disagree with each other more than you would expect.
Read
Nothing matches these filters
No article matches both the search text and the topic selected. Try clearing one of the two filters.